StockSelector.com
  Research, Select, & Monitor Sunday, February 17, 2019 10:26:46 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aclaris Therapeutics, Inc.$7.42($.02)(.27%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aclaris Therapeutics, Inc. has an overall rank of 2591 out of 5882 stocks based on 3 positive rankings and 2 negative rankings.

Positive Rankings
PEGValue
Aclaris Therapeutics has a PEG Value of $18.47. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 148.97% in the next year. Among companies with a PEG Value above the current stock price, Aclaris Therapeutics is ranked 306.
Low Put/Call
Aclaris Therapeutics has a low Put/Call ratio of 0.29 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 830.
10 Day Gain
Aclaris Therapeutics rank is 1027
Negative Rankings
90 Day Loss
Aclaris Therapeutics rank is 343
High vPut/Call
Aclaris Therapeutics has a high Put/Call ratio of 1.06 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 1168.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.